To date, detailed mechanisms which mediate the obesity-driven effect on cancer development in humans are still poorly understood though chronic inflammation, the insulin/insulin growth factor (IGF)-1 axis as well as changes in adipokine signaling and in the intestinal microbiome are known to participate in cancer progression [5,12]. This evidence concerns the gene IGF1 and cancer.